Related Experiment Video
Updated: Jan 23, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Photocytotoxic Pt(iv) complexes as prospective anticancer agents.
Giovanni Canil1, Simona Braccini1, Tiziano Marzo2
1Department of Chemistry and Industrial Chemistry, University of Pisa, Via G. Moruzzi 13, 56124 Pisa, Italy. chiara.gabbiani@unipi.it.
New platinum(IV) complexes show promise as photoactivatable anticancer drugs. These compounds are stable in the dark but become cytotoxic upon light exposure, offering a targeted photochemotherapy approach.
Area of Science:
- Inorganic Chemistry
- Medicinal Chemistry
- Materials Science
Background:
- Platinum(IV) complexes offer advantages over Platinum(II) drugs, including enhanced stability and reduced side effects.
- Photoactivatable platinum(IV) complexes enable targeted drug delivery via photochemotherapy.
- Expanding the library of photoactivatable platinum(IV) prodrugs is crucial for advancing cancer treatment.
Purpose of the Study:
- To synthesize and characterize novel photoactivatable platinum(IV) complexes.
- To investigate the stability, photoreduction, and cytotoxic activity of these new compounds.
- To elucidate the mechanism of action, including interactions with biological targets.
Main Methods:
- Oxidation of a platinum(II) precursor using PhICl2 or H2O2 to form platinum(IV) complexes.
- Characterization of the synthesized platinum(IV) complexes using spectroscopic and electrochemical methods.
- Assessment of cytotoxicity against A2780 and A2780cis cancer cell lines and evaluation of interactions with protein and DNA models via mass spectrometry.
Main Results:
- Two novel platinum(IV) complexes, [PtCl3(4'-phenyl-2,2':6',2''-terpyridine)][CF3SO3] (2) and [Pt(OCOCH3)2Cl(4'-phenyl-2,2':6',2''-terpyridine)][CF3SO3] (3), were synthesized.
- Complexes 2 and 3 demonstrated stability in physiological conditions and underwent photoreduction to the platinum(II) precursor upon irradiation at 365 nm.
- Complex 3 exhibited lower dark toxicity and significantly enhanced photocytotoxicity compared to cisplatin, with notable stability in the presence of glutathione.
Conclusions:
- The synthesized platinum(IV) complexes function as effective prodrugs, releasing active platinum species upon light activation.
- Complex 3 shows particular promise for photochemotherapy due to its tunable stability and potent photo-induced cytotoxicity.
- These findings contribute to the development of advanced platinum-based anticancer agents with improved therapeutic potential.
Related Concept Videos
Electron Transport Chain: Complex III and IV
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Subviral Agents
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Formation of Complex Ions

